The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
 
Laurien Joanna Zeverijn
No Relationships to Disclose
 
Eleonora Looze
No Relationships to Disclose
 
Subotheni Thavaneswaran
Research Funding - AstraZeneca (Inst); Elevation Oncology (Inst); Roche/Genentech (Inst)
 
Jade M. van Berge Henegouwen
No Relationships to Disclose
 
John Simes
Consulting or Advisory Role - FivePhusion (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Louisa Rose Hoes
No Relationships to Disclose
 
Birgit Geurts
No Relationships to Disclose
 
Lucille Sebastian
Research Funding - AstraZeneca/MedImmune (Inst); Merck KGaA (Inst); Roche (Inst)
 
Paul Roepman
No Relationships to Disclose
 
Frank Po-Yen Lin
No Relationships to Disclose
 
Anne M.L. Jansen
No Relationships to Disclose
 
Wendy W.J. de Leng
No Relationships to Disclose
 
Vincent van der Noort
No Relationships to Disclose
 
Lindsay V.M. Leek
No Relationships to Disclose
 
Filip Yves Francine Leon De Vos
Research Funding - Agios (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
 
Henk M.W. Verheul
Consulting or Advisory Role - lava therapeutics (Inst); Philips Healthcare (Inst)
 
Hans Gelderblom
Research Funding - AmMax Bio (Inst); AmMax Bio (Inst); Daiichi (Inst); Deciphera (Inst); Ipsen (Inst); Novartis (Inst)
 
David Morgan Thomas
Employment - Australian Unity
Honoraria - Roche
Research Funding - Amgen; AstraZeneca; Bayer; Elevation Oncology; George Clincal (Inst); InterVenn Biosciences; Lilly (Inst); Microba (Inst); Pfizer; Roche; Seagen (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Amgen
 
Emile E. Voest
Leadership - Mosaic Therapeutics; Sanofi
Stock and Other Ownership Interests - Mosaic Therapeutics; Sanofi
Consulting or Advisory Role - Biogeneration Ventures; InteRNA
Research Funding - astrazeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)
 
Katrin Marie Sjoquist
Honoraria - BMS; Merck; MSD; Novotech (Inst); Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech